Optimizing Patient Selection for Revascularization in Chronic Coronary Syndrome: Rethinking Strategies for Improved Outcomes
Novel Insights on Revascularization in Chronic Coronary Syndromes
DOI:
https://doi.org/10.5281/zenodo.8118795Keywords:
Atherosclerosis, chronic coronary syndrome, revascu-larization, stable coronary artery diseaseAbstract
Current guidelines regarding the revascularization of patients with chronic coronary syndromes remains equivocal and while providing a general opinion, many frequently encountered situations in daily practice are still uncovered. Novel studies and trials are aiming to find the determinants of improved outcomes after revascularization and give an insight to the clinicians in decision making. Despite the controvertial results, it seems that more detailed and precise indications are to be defined in the future.
References
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal. 2019;41(3):407-77.
Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. New England Journal of Medicine. 2018;379(3):250-9.
Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. Bmj. 2014;348:g3859.
Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2018;40(2):87-165.
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;79(2):e21-e129.
Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, et al. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation. 2016;134(18):1314-24.
Murphy ML, Hultgren HN, Detre K, Thomsen J, Takaro T. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med. 1977;297(12):621-7.
Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563-70.
Bittl JA, He Y, Jacobs AK, Yancy CW, Normand SL. Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation. 2013;127(22):2177-85.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. New England Journal of Medicine. 2020;382(15):1395-407.
Ahn JM, Park DW, Lee CW, Chang M, Cavalcante R, Sotomi Y, et al. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials. JACC Cardiovasc Interv. 2017;10(14):1415-24.
Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391(10124):939-48.
Boden WE. Which Is More Enduring — FAME or COURAGE? New England Journal of Medicine. 2012;367(11):1059-61.
Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography. Circulation. 2003;107(23):2900-7.
Pijls NHJ, van Schaardenburgh P, Manoharan G, Boersma E, Bech J-W, van’t Veer M, et al. Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis: 5-Year Follow-Up of the DEFER Study. Journal of the American College of Cardiology. 2007;49(21):2105-11.
Bech GJW, Bruyne BD, Pijls NHJ, Muinck EDd, Hoorntje JCA, Escaned J, et al. Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis. Circulation. 2001;103(24):2928-34.
Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van `t Veer M, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. New England Journal of Medicine. 2009;360(3):213-24.
Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, et al. Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome. Journal of the American College of Cardiology. 2010;55(21):2399-407.
Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, et al. Prognostic Value of Fractional Flow Reserve: Linking Physiologic Severity to Clinical Outcomes. Journal of the American College of Cardiology. 2014;64(16):1641-54.
Mintz GS, Guagliumi G. Intravascular imaging in coronary artery disease. The Lancet. 2017;390(10096):793-809.
Ozgul N, Acar E. How Does Intravascular Imaging Assist Interventional Cardiologists? Enhancing Interventions with Intravascular Imaging. Advances in Cardiac Research. 2023;1(1).
Hong S-J, Kim B-K, Shin D-H, Nam C-M, Kim J-S, Ko Y-G, et al. Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. JAMA. 2015;314(20):2155-63.
Buccheri S, Franchina G, Romano S, Puglisi S, Venuti G, D’Arrigo P, et al. Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients. JACC: Cardiovascular Interventions. 2017;10(24):2488-98.
De Bruyne B, Pijls NHJ, Kalesan B, Barbato E, Tonino PAL, Piroth Z, et al. Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease. New England Journal of Medicine. 2012;367(11):991-1001.
Witzenbichler B, Maehara A, Weisz G, Neumann F-J, Rinaldi MJ, Metzger DC, et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents. Circulation. 2014;129(4):463-70.
Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circulation: Cardiovascular Interventions. 2016;9(4):e003700.
Koo B-K, Hu X, Kang J, Zhang J, Jiang J, Hahn J-Y, et al. Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI. New England Journal of Medicine. 2022;387(9):779-89.
Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine. 2007;356(15):1503-16.
Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-91.
Navarese EP, Lansky AJ, Kereiakes DJ, Kubica J, Gurbel PA, Gorog DA, et al. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. European Heart Journal. 2021;42(45):4638-51.
Sidhu MS, Alexander KP, Huang Z, O'Brien SM, Chaitman BR, Stone GW, et al. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial. Am Heart J. 2022;248:72-83.
Bolognese L, Reccia MR, Sabini A. Long-term follow-up after invasive or conservative management of stable coronary disease: the ISCHEMIA-EXTEND study. Eur Heart J Suppl. 2023;25(Suppl B):B34-b6.
Al-Lamee R, Thompson D, Dehbi H-M, Sen S, Tang K, Davies J, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. The Lancet. 2018;391(10115):31-40.
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. New England Journal of Medicine. 2009;360(24):2503-15.
Volodarskiy A, Kumar S, Amin S, Bangalore S. Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease. The American Journal of Medicine. 2016;129(12):1288-98.
Liao G-z, Li Y-m, Bai L, Ye Y-y, Peng Y. Revascularization vs. Conservative Medical Treatment in Patients With Chronic Kidney Disease and Coronary Artery Disease: A Meta-Analysis. Frontiers in Cardiovascular Medicine. 2022;8.
Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. New England Journal of Medicine. 2020;382(17):1608-18.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Advances in Cardiac Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
